Ensemble method of transfer learning Deep learning and vision transformer influencing explainable AI for Breast Cancer Prediction

Technical Summary: Ensemble Method of Transfer Learning, Deep Learning, and Vision Transformer Influencing Explainable AI for Breast Cancer Prediction

Problem Statement
Breast cancer (BCr) identification via histopathological image analysis remains a critical challenge in medical diagnostics. While Deep Learning (DL) and Convolutional Neural Networks (CNNs) have advanced the field, significant gaps persist regarding the handling of imbalanced datasets and the "black box" nature of model decision-making, which hinders clinical trust and adoption. Furthermore, existing methods often struggle with generalizability across different magnification levels and lack sufficient interpretability for healthcare providers. The paper addresses the need for a system that not only achieves high diagnostic accuracy but also provides transparent, explainable reasoning for its predictions to facilitate clinical integration.

Methodology
The proposed framework utilizes an Ensemble Transfer Learning (ETL) approach that fuses pre-trained CNN architectures with Vision Transformer (ViT) models, augmented by Explainable AI (EXAI) techniques.

• Dataset: The study employs the BreakHis dataset, comprising 7,909 histopathological images from 82 patients. The data is categorized into benign and malignant tumors and includes four magnification levels: 40X, 100X, 200X, and 400X.
• Base Models: Four pre-trained CNN architectures were selected for transfer learning: InceptionV3, InceptionResNetV2, ResNet101, and Xception. These were fine-tuned on the BreakHis dataset.
• Ensemble Architecture: The core innovation is the fusion of these CNN models with a Vision Transformer (ViT). The ViT processes image patches using a self-attention mechanism to capture long-range dependencies, while the CNNs provide robust local feature extraction. The ensemble combines the strengths of these distinct architectures to enhance feature representation and reduce overfitting.
• Training Configuration: Images were resized to 128 × 128 pixels. The models were trained using the Adam optimizer with a learning rate of 1e-5 and a batch size of 32 over 30 epochs. The dataset was split into 70% for training and 30% for testing.
• Explainable AI (EXAI): To ensure transparency, the study integrates four visualization techniques:
  • Grad-CAM: Generates heatmaps highlighting regions in the last convolutional layer that contribute most to the prediction.
  • Heat Maps: Visualizes the model's focus areas.
  • LIME (Local Interpretable Model-agnostic Explanations): Provides instance-based, localized explanations by identifying key histological features.
  • Occlusion Sensitivity (OS): Determines the importance of specific image regions by observing prediction changes when parts of the image are occluded.

Key Contributions

1. Hybrid Ensemble Model: The paper introduces a ResNet101-ViT fusion model that leverages Ensemble Transfer Learning (ETL) to overcome the limitations of standalone CNNs, such as overfitting and bias.
2. Multi-Magnification Evaluation: The system is rigorously evaluated across four distinct magnification levels (40X, 100X, 200X, 400X), demonstrating robustness regardless of image scale.
3. Enhanced Interpretability: By applying Grad-CAM, LIME, and OS, the study bridges the gap between AI predictions and clinical decision-making, offering visual evidence of the model's focus on malignant or benign tissue characteristics.
4. Comparative Analysis: The work provides a comprehensive comparison between standard Transfer Learning (TL) models and the proposed ETL-ViT ensemble, quantifying the performance gains.

Results
The experimental results indicate that the ensemble approach significantly outperforms individual Transfer Learning models and previous state-of-the-art methods.

• Performance Metrics: The ResNet101+ViT ensemble achieved the highest performance across all metrics on the BreakHis dataset. Specifically, at 40X magnification, the model attained:
  • Accuracy: 96.82%
  • Precision: 96.78%
  • Recall: 95.69%
  • Specificity: 95.79%
  • F1-Score: 96.17%
• Comparative Superiority: The proposed model consistently outperformed individual CNNs (e.g., standalone ResNet101 achieved ~89.4% accuracy at 40X) and other ensemble or hybrid methods cited in the literature (e.g., Xception+SVM, DenseNet+MLP).
• Robustness: The model maintained high accuracy across all magnifications, with the 40X setting yielding the best classification results (96.82% accuracy), while 400X achieved 95.60%.
• Visual Validation: The confusion matrices and ROC curves (AUC of 0.996 at 40X) confirmed the model's ability to minimize False Positives and False Negatives. The EXAI visualizations successfully highlighted relevant tumor regions, validating that the model's decisions were based on clinically significant features.

Significance and Claims
The paper claims that the integration of Vision Transformers with Transfer Learning via an ensemble method represents a significant advancement in breast cancer diagnosis. The primary significance lies in the dual achievement of high accuracy and explainability. By demonstrating that ensemble models are more effective than single TL methods, the study suggests that combining the local feature extraction of CNNs with the global context awareness of ViTs leads to superior diagnostic capabilities.

The authors assert that this approach empowers clinicians by providing not just a prediction, but a visual justification (via Grad-CAM and LIME) for that prediction, thereby increasing trust in AI-driven diagnostics. The study concludes that while the current model is highly accurate, future work must address computational efficiency and validate these findings on diverse, external datasets to ensure global applicability. The work positions itself as a step toward "smart healthcare" where AI tools are transparent, reliable, and capable of early, precise detection of breast lesions.